What’s your opinion on the recent court ruling about FDA’s role in advising on ivermectin use?

Please enable JavaScript in your browser to complete this form.

In a recent landmark ruling, a federal appeals court in New Orleans ruled in favor of doctors advocating for the use of ivermectin in treating COVID-19. The court agreed that the Food and Drug Administration (FDA) overstepped its legal boundaries in its attempt to dismiss a lawsuit brought by three doctors regarding the use of ivermectin. The court also critiqued the FDA's misleading messaging which failed to inform the public of a human version of ivermectin. This case highlights the limits of FDA's authority, underscoring that it can inform but not advise.

What's your opinion on the recent court ruling about FDA's role in advising on ivermectin use?

The ruling is correct, FDA should not interfere with doctors' practice.
The ruling is wrong, FDA should guide the use of medical treatments.

A federal appeals court in New Orleans ruled Friday that the Food and Drug Administration seriously overstepped their legal authority when trying to mitigate a lawsuit regarding the use of ivermectin for treating COVID-19.